Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon May 14, 2018 10:57am
158 Views
Post# 28026601

RE:RE:RE:RE:meeting next week

RE:RE:RE:RE:meeting next weekSo I'm curious how the system work and you being an 'insider' ( not of the stock, of the industry) I was wondering.
In the circumstances you describe would a 'big buyer' go around the large shareholders to see if they were looking to sell, I'm assuming that would be perfectly legal. It would be a way to get their position or would the 'big seller' not want to show their hand in this way?

SPCEO1 wrote: My best guess as to what is goign on is that US institutions are just discovering what we have known for a long time. And they are probably finding out about it via their interest in Taimed. If they were excited about Taimed, then how much more interested in buying TH should they be?

So, they are likely in a mode where they are yelling at their traders "push it higher until you find some volume!".  They just want to get in and any price below C$15 may not matter to them as they expect it to at elast double from there.

bfw wrote:
Garp1 wrote:
You might be right, we may get to 12.25$ + your missing 1$ conservatism.


Blew right threw my technical target of $12 that I wrote about 3 weeks ago.

Nice to see higher volumes coming in.

With market cap approaching $1 Billion, surely institutions are sniffing around.

Will they allude to a Nasdaq listing this week?

bfw




Bullboard Posts